O. Beck

发表

Massive pulmonary embolism in a young boy with T-cell leukaemia

C. Martín, G. Staatz, O. Beck, 2014, Hämostaseologie.

Central Venous Access Devices (CVAD) in Pediatric Oncology Patients—A Single-Center Retrospective Study Over More Than 9 Years

O. Muensterer, H. Rossmann, J. Gödeke, 2019, Front. Pediatr..

Multivariate analysis on complications of central venous access devices in children with cancer and severe disease influenced by catheter tip position and vessel insertion site (A STROBE-compliant study).

O. Muensterer, J. Faber, T. König, 2020, Surgical oncology.

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma

C. Paret, J. Faber, Daniel-Christoph Wagner, 2020, Cancers.

Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK).

S. Bens, R. Siebert, J. Gerss, 2020, European journal of cancer.

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL

J. König, C. Paret, A. Russo, 2023, Oncoimmunology.

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy

C. Sommer, C. Paret, D. Solomon, 2017, Oncotarget.

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation

C. Sommer, K. Frauenknecht, C. Paret, 2023, International journal of molecular sciences.

Hereditary Spherocytosis: Can Next-Generation Sequencing of the Five Most Frequently Affected Genes Replace Time-Consuming Functional Investigations?

C. Paret, O. Beck, F. Häuser, 2023, International journal of molecular sciences.